OTCPicks.com Stocks to Watch for Friday, June 6th TRCA, PCYC, SRSR

OTCPicks.com’s Daily Small Cap and Microcap Newsletter presents a range of the hottest small cap stocks on trading on the OTC and OTCBB markets.  In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and microcap traders to meet up and discuss their top stock picks. Visit http://www.otcpicks.com/ today to join this growing community.

Our Stocks to Watch tomorrow include Tercica Inc. (NASD: TRCA), Pharmacyclics Inc. (NASD: PCYC), Sarissa Resources Inc. (OTC: SRSR)

To view the complete Stocks to Watch newsletter please visit: http://www.otcpicks.com/stocks-to-watch/index.php

For more in-depth coverage of small cap stocks visit http://www.otcpicks.com

TERCICA INCORPORATED (NASD: TRCA)

"Up 99.55% on Thursday"

For Detailed Quote & Latest Company News go to:

http://www.otcpicks.com/quotes/TRCA.php

Tercica, Inc., a biopharmaceutical company, engages in the development and marketing of endocrine products. It markets Increlex, a replacement therapy for the treatment of short stature in children with severe primary insulin-like growth factor-1 deficiency, or severe primary IGFD, and for children with growth hormone gene deletion who have developed neutralizing antibodies to growth hormone. The company, pursuant to a strategic collaboration with Ipsen S.A., has the right to develop and commercialize Somatuline Depot for various indications other than opthalmic indications in the United States and Canada. Somatuline Depot is an injectable sustained-release formulation containing lanreotide, a somatostatin analogue. Tercica markets Increlex to pediatric endocrinologists in the United States. The company was founded in 2000 and is based in Brisbane, California.

PHARMACYCLICS INCORPORATED (NASD: PCYC)

"Up 47.62% on Thursday"

For Detailed Quote & Latest Company News go to:

http://www.otcpicks.com/quotes/PCYC.php

Pharmacyclics, Inc., a pharmaceutical company, is developing drugs to treat cancer and other diseases. Its pharmaceutical agents are synthetic small molecules designed to target key biochemical pathways in diseased cells. The company's product candidate, Xcytrin (motexafin gadolinium) Injection, an anti-cancer agent with a novel mechanism of action, has completed Phase III trials in oncology and is in Phase II trials for patients with non-small cell lung cancer. Its products also include PCI-24781, a histone deacetylase inhibitor in Phase I trial in patients with advanced relapsed solid tumors; PCI-24783, a preclinical stage small molecule inhibitor of Factor VIIa for cancer therapy; and PCI-32765, a preclinical stage small molecule tyrosine kinase inhibitor to treat B cell malignancies and autoimmune disease. Pharmacyclics has a license agreement with the University of Texas to develop and commercialize porphyrins, expanded porphyrins, and other porphyrin-like substances covered by its patents. The company was founded in 1991 and is headquartered in Sunnyvale, California.

SARISSA RESOURCES INCORPORATED (OTC: SRSR)

"Up 28.00% on Thursday"

For Detailed Quote & Latest Company News go to:

http://www.otcpicks.com/quotes/SRSR.php

Sarissa Resources is an American junior exploration company that identifies and explores mineral properties in North America. Currently, Sarissa has interests in properties with base metal, precious metal, uranium and niobium prospects in Northern Ontario, Canada.

About OTCPicks.com

OTCPicks.com is fast becoming the premier Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Research Reports authored by our financial writers. We publish our Daily Market Movers Digest Newsletter to opt-in investor members. OTCPicks.com presents the latest information for the discerning small cap and microcap investor.  The site features informative articles on microcap investing, the top penny stock picks, and a wealth of small cap research on vertical markets. To feature a company on OTCPicks.com, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.

Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

Disclosure: OTCPicks.com has not been compensated by any of the companies covered in this release.

OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.